The store will not work correctly when cookies are disabled.
(S)-N-(2-amino-2-oxoethyl)-4-methyl-2-((S)-pyrrolidin-2-ylmethylamino)pentanamide
ID: ALA4762271
Chembl Id: CHEMBL4762271
PubChem CID: 131032
Max Phase: Preclinical
Molecular Formula: C13H26N4O2
Molecular Weight: 270.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)C[C@H](NC[C@@H]1CCCN1)C(=O)NCC(N)=O
Standard InChI: InChI=1S/C13H26N4O2/c1-9(2)6-11(13(19)17-8-12(14)18)16-7-10-4-3-5-15-10/h9-11,15-16H,3-8H2,1-2H3,(H2,14,18)(H,17,19)/t10-,11-/m0/s1
Standard InChI Key: YXMUYZBZHWHMEP-QWRGUYRKSA-N
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 270.38 | Molecular Weight (Monoisotopic): 270.2056 | AlogP: -0.66 | #Rotatable Bonds: 8 |
Polar Surface Area: 96.25 | Molecular Species: BASE | HBA: 4 | HBD: 4 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 13.15 | CX Basic pKa: 10.24 | CX LogP: -0.70 | CX LogD: -3.41 |
Aromatic Rings: 0 | Heavy Atoms: 19 | QED Weighted: 0.47 | Np Likeness Score: -0.06 |